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Tolerance of the VocaLogÔ Vocal Monitor by Healthy
Persons and Individuals With Parkinson Disease
Jeff Searl and Angela M. Dietsch, Kansas City, Kansas
Summary: Objective. To assess subject tolerance of extended use of the VocaLogÔ vocal monitor (VM), a device
marketed to log calibrated decibel sound pressure level.
Study Design. Prospective between-subjects design including two age- and sex-matched groups: individuals with
Parkinson disease (IWPD) and healthy persons.
Methods. After an initial session to calibrate the device and demonstrate its use, participants wore the VM during
waking hours for five consecutive days. At a second visit to return the VM, participants completed a survey and a short
interview regarding their experience with and perceptions of the device.
Results. Those with PD and control subjects reported relatively few issues with use of the VM. There were no group
differences regarding convenience, others’ reactions, technical issues, or future participation in similar studies. Participants with PD indicated similar frequency of discomfort issues but higher severity ratings for discomfort during VM
use compared with healthy participants.
Conclusions. The VocaLogÔ offers a method to monitor vocal loudness during everyday activities for several
consecutive days. The device was well tolerated by participants from both groups. IWPD reported greater discomfort
than controls, possibly reflecting altered sensory perceptions associated with PD. The current data offer some reassurance that this VM can be tolerated by both healthy persons and those with PD for clinical and research purposes.
Key Words: Voice monitor–Parkinson disease–Instrumentation.
INTRODUCTION
Speech-language pathologists working in the area of voice disorders use a variety of aerodynamic, acoustic, perceptual, and
other measurements of vocal function.1,2 Instrumental
measures may be useful for describing the voice, making
diagnoses, and tracking voice changes as a function of time,
disease state, or interventions.3 Currently, instrumental measures are typically collected in a clinical environment because
of factors such as environmental control, lack of portability,
cost, and risk of instrumentation damage.
Effective diagnosis and management of voice disorders depends on accurate information about vocal behaviors on a
day-to-day basis. Furthermore, initial treatment in the clinic
can establish healthier voice patterns in cases of overuse or
underuse, but this is only functional if targets are carried over
to home and work situations. In instances such as these, it would
be ideal to sample patients’ voices in their own daily environments. Portable devices for sampling voicing outside of the
clinic have become available recently and vary by the type of
data recorded, the length of recording capacity, the physical parameters of the device, and pricing.4 Per the manufacturer’s
website, the Ambulatory Phonation Monitor (KayPENTAX,
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Montvale, NJ) includes an accelerometer that adheres to the
skin of the neck and a sizable recording box that can record
approximately 18 hours of data regarding estimated sound pressure level (SPL) and fundamental frequency (F0). The VoxLog
(Sonovox AB, Umea, Sweden) uses an accelerometer, an environmental microphone, and a pocket-sized monitor, with a
maximum recording duration of 7 days for SPL and F0 data according to the manufacturer’s website. The VocaLogÔ (Griffin
Labs, Temecula, CA) is a smaller vocal monitor (VM) designed
to track vocal activity including decibel (dB) and phonation
time for up to 3 weeks via a contact microphone and is commercially available at roughly one-fifth the cost of other portable
VMs. The high portability and low cost of the VocaLogÔ
make it an appealing clinical option. However, tolerance for
wearing the device has not yet been evaluated.
Dysphonia is a prevalent symptom among individuals with
Parkinson Disease (IWPD), and increased loudness is a primary
target across most current treatment strategies.5 A portable means
of monitoring vocal loudness across settings would be especially
helpful in this population because impairments in motor
learning6,7 may negatively impact carryover effects of voice
treatment. However, the neuropathologies underlying PD have
also been show to affect sensorimotor integration, resulting in
abnormal perception that may affect IWPD’s tolerance for
wearing the monitoring device during daily activities.
Schalling et al collected subjective feedback from six IWPD
who wore the previously described VoxLog. They reported
positive responses to questions about ease of use, wearing the
device again, and handling of the VoxLog, but some negative
feedback was also provided. This included three of six IWPD
indicating that the device was ‘‘unwieldily large,’’ one
indicating it was difficult to wear, another reporting a tight fit
on the neck, and some relaying that people in the community
commented about the presence of the device.8 Although positive
overall, these responses do suggest that wearing some type of
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monitor may be perceived negatively by IWPD. Similarly mixed
reviews were reported by Hunter, in a study of teachers (n ¼ 14)
who wore an early version of a voice dosimeter developed by The
National Center for Voice and Speech for 2-week intervals. The
dosimeter included an accelerometer at the base of the neck and a
data logging device (larger than the VM used in the present
study). The teachers reported an overall positive experience.
However, negative feedback was provided on survey items
regarding skin irritation on the neck, carrying the dosimeter
throughout the day, inconvenience, and visibility of the device
by communication partners (one of whom expressed concern
about recording of conversation).8 We are unaware of studies
that compared user experiences with a VM across subject
populations.
The purpose of this study was to obtain user feedback
regarding convenience, comfort, and distraction during use of
the VocaLog and to compare responses from IWPD and healthy
controls. Feedback from those wearing a VocaLogÔ has not
been reported. Each monitor on the market has its own physical
(size, weight, and so forth) and user features that could create
unique user experiences. We hypothesized that IWPD would
find the VM less convenient, less comfortable, and more distracting than their healthy peers.
METHODS
Participants
Twenty adults with idiopathic PD and 20 age- and sex-matched
adults without PD participated. The IWPD were 11 males and
nine females between the ages of 47–89 years (mean: 64.5 years)
with the PD diagnosis confirmed by their treating neurologist.
None of the IWPD had hearing impairments, previous surgery
or neurological conditions (other than PD) that might affect
speech, or previous neurosurgical intervention for PD management. Individuals in the non-PD group had normal hearing and
speech and no history of surgery or disease that might affect
speech or sensory perception. They were age matched to
IWPD within ±2 years (mean: 64.7 years). All participants provided written informed consent for study participation after verbal and written review of the purpose, duration, and nature of the
study. The study was approved by the Human Subjects Committee at the University of Kansas Medical Center.
Instrumentation
Each VocaLogÔ unit consists of a pager-sized monitor, a contact microphone held in place by an adjustable band partially
surrounding the neck, a monitor-to-microphone cord, and the
VocaLogÔ software. A manufacturer-provided docking station
and USB cable were used during calibration but were not part of
the daily wear and maintenance performed by participants.
Based on manufacturer reports, there are some differences in
the analysis window and estimating procedures for loudness
by the VocaLogÔ compared with other devices. Details
regarding the device’s methodology and accuracy for discriminating between phonatory activity and other sounds, indexing
parameters associated with vocal loudness, and estimating
speaking time were not clearly defined in the manufacturer’s
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description of the device. Results of a previous investigation,
which indicated the device was accurate in logging silence
and dB values that were strongly correlated with a trusted
external sound level meter, have been reported elsewhere.10
The device is also capable of real-time tactile feedback
although this feature was not used in this study. The
investigator-authors had no involvement in the development,
manufacture, or sale of the device.

Procedures
Each participant attended two study sessions in the laboratory
and wore the VM for several intervening days as part of another
study protocol. During the first session, the contact microphone
was custom fit for comfortable wear, participants were provided
with instructions and practice for donning/doffing the device, and
the VM was calibrated. Participants left the session with the VM
in place and wore it during waking hours for 5 consecutive days
while performing their normal daily activities. They returned to
the laboratory and completed a post-study questionnaire
(Appendix A), as well as additional voice recordings for other
protocols. Using 10-cm visual analog scales (VAS), wherein
0 represented no problems for a parameter and 100 indicated
maximum difficulty, each subject rated: comfort, distraction to
the speaker, distraction to the listening partner, convenience,
and embarrassment factors. They also answered several other
queries regarding whether they would advise others to use such
a device, technical issues across the 5 days of wear, and factors
pertaining to participation in the study (motivation to contribute
to research, time involved, and so forth).
Calipers were used to measure from the left end of the VAS
line to the subject’s mark for each of the 5 main ratings. These
data were compared across groups using t tests. Comments
from the related interviews were categorized, tallied, and
compared across groups via chi-square tests.

RESULTS
Mean ratings clustered in the lowest 30% of the VAS for both
groups across all ratings. IWPD reported higher scores (ie,
lower tolerance) than non-PD participants in all areas except
embarrassment, but differences were statistically significant
only for overall comfort (Table 1). The IWPD’s mean rating
(32.9 mm) was statistically significantly higher than the controls (21.1 mm) and indicated a greater sense of discomfort
by the PD group.
Responses to the open-ended interview questions revealed
further details about the experiences of IWPD and controls
who used the VM. There was a trend toward greater frequency
of complaints within the PD group for categories of convenience, discomfort, and technical issues, but group differences
did not reach statistical significance for any category or subcategory (Table 2).
A majority of participants from each group reported some inconveniences associated with use of the VM (75% of IWPD and
65% of controls). Positioning of the device and cord during
everyday activities (and associated wardrobe issues such as
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TABLE 1.
Visual Analog Scale (VAS) Ratings out of 100 mm From
Individuals With Parkinson Disease (PD) and Healthy
Controls who Wore the VocaLogÔ Monitor for Several
Days
VAS Rating
(mm)
PD
Convenience
Mean
30.7
SD
19.6
Comfort
Mean
32.9
SD
17.9
Distraction to user
Mean
24.8
SD
21.3
Distraction to others
Mean
17.9
SD
21.4
Embarrassment
Mean
6.9
SD
7.3

Control

T

df

P

21.5
17.4

1.576

38

0.123

21.1
16.5

2.153

38

0.038

16.9
21.7

1.152

38

0.256

15.6
21.9

0.329

38

0.744

7.9
11.8

0.338

38

0.737

Abbreviation: SD, standard deviation.
The bolded p-value indicates that the group differences achieved statistical significance at less than or equal to .05.

choosing pants with pockets to hold the VM) were the most
prevalent convenience-related criticisms.
Group differences in comfort were not present but sizable percentages of each group reported discomfort (50% of IWPD and
35% of controls). Participants who reported discomfort
described specific feelings of itchiness, sweatiness, and tightness
associated with the neck microphone, and general awareness of
the VM’s presence. The discomfort was generally not severe
enough to interfere with study participation. One IWPD experienced neck irritation to a degree that caused him to discontinue
wearing the VM after the first day of data logging.
The PD and control groups did not differ in the proportion
who noticed reactions to the VM from communication partners
or others during daily activities. Although there were not group
differences, the majority of users in each group (60% of IWPD
and 65% of controls) reported some reaction from others. Sixty
percent of participants indicated that others had obviously
noticed and/or inquired about the device. Two control participants noted that communication partners expressed concern
about conversations being recorded. Study participants across
groups reported that an average of 3.6 people inquired about
the VM device over the 5 days of wear with a range of 0 to
more than 20 inquiries reported.
The groups did not differ in terms of self-reported technical
issues related to wearing the device. The majority of participants indicated no technical issues (75% of IWPD and 90%
of controls). There did not appear to be any particular technical
issue that occurred with higher frequency than others.
Finally, most participants from both groups indicated that they
would volunteer to wear the VM device for another study in the

future (100% of IWPD and 85% of controls) and would
encourage others to do so (95% of both groups). Of those who
offered specific reasons for these responses, a desire to contribute
to research, ease of use, and minimal discomfort were cited as incentives, whereas the time and expense of traveling to the study
site were deterrents.

DISCUSSION
The VM is intended for home use by individuals with voice
issues or with suspected voice issues. Individuals who wore
the device across several consecutive days reported some perceptions that need to be considered by those interested in using the VMs. Additionally, detailed information about the
user experience might enable providers to preemptively
address any potential challenges to the utilization of the
VM for a given user.
Although no group differences were observed, sizable percentages of both the PD and control groups reported issues
with the convenience of wearing the device. Most of these concerns pertained to positioning the device, microphone, and
cord, and to planning wardrobe choices to accommodate the device. Simple adaptations such as the use of a nonslip substance
like Dycem on the microphone might prevent it from shifting
during wear without making the device tighter on the neck.
The addition of a belt clip to the logging device would likewise
ease its placement. A few participants from both groups reported that wearing the VM disrupted their daily routine.
Although virtually all users indicated they would wear the device again and would even encourage others to wear one, clinicians might need to talk to potential users about ways to
minimize inconvenience and to possibly convey a strong rationale for why wearing the device is important. Overall, the current findings are in general agreement with Schalling et al who
also evaluated feedback from IWPD after wearing a monitor
that was similar, but not identical, to the VM. That is, users reported a positive response in general, but also some negative
feedback regarding its wear and noticeability by communication partners.
Participants in the PD group reported similar frequency and
types of complaints about discomfort as those from the control
group, but the intensity of IWPD’s discomfort as rated on the
VAS was higher than the controls. This may be a reflection of
nonmotor symptoms of PD, which include both sensory and
neuropsychiatric components. Mounting evidence indicates
that IWPD exhibit altered sensation and sensory integration of
auditory, visual, and pain cues.6,11–14 Both peripheral and
central sources of distorted sensation in PD have been
described.15 The basal ganglia appear to have a key role in sensory gating, in that they can inhibit cortical responses to sensory
information.11,16,17 The insula also has been implicated as
contributing to nonmotor symptoms of PD.18 PD-related changes
in certain brainstem nuclei and neurotransmitters appear to alter
the excitability of neurons associated with pain modulation.19
Histological studies identified abnormalities in the pharyngeal
nerves of IWPD.20 Because of these disruptions in afferent neurophysiology, IWPD may actually sense pain differently than their
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TABLE 2.
Comparison of the Proportion of Parkinson Disease (PD) and Control Group Subjects Reporting Specific Types of
Inconvenience, Discomfort, Reactions by Others, and Technical Issues Related to Wearing the VocaLogÔ Monitor

Inconvenience
None
Device placement and cord issues
Wardrobe issues
Social activity concern
Disrupted daily routine
Discomfort
None
Related to cord
Related to microphone position
Related to sensation on neck
Reactions by others
None
Inquired about device/study
Noticed but did not ask
Assumed other purpose for VM
Fear of being recorded
Technical issues
None
Beeping/vibrating
Accidentally pushing button
Not knowing VM was on/off
Positioning of device
Cord catching/unplugging
Future participation
Volunteer for similar study again
Encourage others to volunteer
No reasons provided
Motivation: research contribution
Motivation: easy to use
Motivation: minimal discomfort
Disincentive: transportation cost

PD (N)

Control (N)

c2

P

5
11
2
2
3

7
7
4
3
3

0.476
1.616
0.784
0.229
0.000

0.490
0.204
0.376
0.633
1.000

10
3
4
5

13
0
4
3

0.921
3.243
0.000
0.625

0.337
0.072
1.000
0.429

8
7
5
4
0

7
6
6
4
2

0.107
0.114
0.125
0.000
2.105

0.744
0.735
0.724
1.000
0.147

15
2
0
0
2
1

18
0
1
1
0
0

1.558
2.105
1.026
1.026
2.105
1.026

0.212
0.147
0.311
0.311
0.147
0.311

20
19
9
7
2
3
2

17
19
12
4
3
0
0

3.243
0.000
9.023
1.129
0.229
3.243
2.105

0.072
1.000
0.342
0.288
0.633
0.072
0.147

Notes: There were no statistically significant group differences for any variable.

non-PD peers. Additionally, neuropsychiatric issues such as anxiety, depression, and sleep disorders have been widely described
in PD21 and are associated with lower quality of life scores and
higher pain levels across a number of chronic diseases such as fibromyalgia,22 multiple sclerosis,23 and PD.24,25 The higher
discomfort ratings reported by IWPD are consistent with other
reports of nonmotor symptoms of PD and must be considered
when using the VM in IWPD.
The results of the present study suggest that the use of a
voice monitoring device may affect the speaker’s communication behaviors as well as those of their interaction partners.
First, the very presence of the device used by Schalling et al8
served as a reminder to speak louder and more often according to participant reports. Furthermore, Hunter reported that
7 of 14 teachers felt the dosimeter affected their voice (unspecified as to how) and 5 never reached a point that they
were unaware of the monitor when wearing it even after
2 weeks of continuous use.9 The current findings along
with those from Schalling et al and Hunter suggest that sim-

ply wearing a VM may alter when and how the wearer communicates. Second, the majority of people wearing the VM in
the present investigation as well as all 14 teachers from
Hunter’s study reported that others commented on or noticed
the device.9 Although the impact of the device on the
communication behavior of those with whom the wearer is
interacting was not measured in any of the referenced studies,
the potential implications must be considered in evaluating
any data logged by the device. Eliminating the wearer’s
awareness of the monitor may be impossible, but the effects
on conversation partners may be minimized if the user takes
steps to fully conceal the device under clothing. Alternatively, participants and their communication partners should
be reassured that the VM is only capable of logging vibrations of the neck tissue and therefore cannot record articulatory movements or ambient sounds from other speakers or
the environment. Finally, advances in smartphone technology
may offer more socially acceptable and cost-effective means
of monitoring voice use over time.26
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Few technical issues were reported by wearers from either
group. This could be a reflection of the relatively simple design
of the device, the brief training provided at the initial session, or
the technological savvy of the participants. The VM, as configured for this study, did not require participants to push its single
button or unplug the microphone for any reason. Additionally,
the contact microphone was held in place by a flexible semicircular band that was fit to each participant’s neck during the first
visit; no adhesive was necessary.
In summary, participants generally found the VM to be innocuous, to the extent that they would use the device again and
recommend it to others. There were few group differences in
tolerance ratings in contrast to the expected outcome. The minimal inconvenience and discomfort associated with VM use appeared to be outweighed by the perceived advantages such as
contributing to the advancement of research even without personal benefit. These results extend the findings of previous
studies using larger devices, wherein healthy participants and
those with PD reported occasional physical and social discomfort associated with VM use. The specific and detailed feedback
from participants in this study offers opportunities to make the
VM more acceptable to future wearers. The results of this study
suggest that the VocaLog could be tolerated by a variety of populations in future studies with minimal modifications.
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APPENDIX A
POST-STUDY QUESTIONNAIRE

Please answer the following questions as honestly and with as much detail as possible. For the
items that ask you to rate a particular aspect of the vocal monitor, please place a slash or “tic”
mark on the line to indicate your rating.
Convenience
1. Please rate how convenient the Vocal Monitor was to use:

Extremely convenient

extremely inconvenient

2. Please explain any specific problems you had with the Vocal Monitor that made its use
inconvenient:
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
3. Did you have any difficulty remembering to wear the Vocal Monitor in the morning? If
so how frequently did this occur?
________________________________________________________________________
_______________________________________________________________________
Comfort:
4. Please rate how comfortable you found the Vocal Monitor:

Extremely comfortable

extremely uncomfortable

5. Please explain any specific problems you had with the Vocal Monitor related to how comfortable
it was to use:
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
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Distraction:
6. Please rate the level of distraction/disruption wearing the Vocal Monitor created in your daily
life:

Little to no distraction

high level of distraction

7. Did wearing the Vocal Monitor keep you from engaging in any of your normal daily activities?
Please explain:
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________

8. Please rate the level of distraction the Vocal Monitor created for people that you talked to during
your daily activities:

Little to no distraction

high level of distraction

9. Did other people ask you about the Vocal Monitor? If so, approximately how many?
___________________________________________________________________________
10. Please describe some of the reactions other people had to your Vocal Monitor:
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
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11. Please rate the level of embarrassment you felt while wearing the Vocal Monitor:

little to no embarrassment

Extremely embarrassed

12. Did you find the Vocal Monitor easy to hide under clothing? Please describe any measures you
took to conceal the Vocal Monitor and if it was successful:
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________

Technical Issues:
13. Did you experience any technical problems with the Vocal Monitor (beeping, or vibrating etc)?
Please explain:
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
________________
14. What advice would you give to other people that may participate in a study using a Vocal
Monitor?
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
15. Would you encourage other people to participate in a study using a Vocal Monitor? Would you
participate in another study using a Vocal Monitor? Why or why not?
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
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